MITO - Stealth BioTherapeutics Corp - ADR
Previous close
0.32
0 0%
Share volume: 0
Last Updated: Tue 15 Nov 2022 06:00:00 AM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.32
0.00
0.00%
Summary score
40%
Profitability
49%
Dept financing
28%
Liquidity
18%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 2016 - 2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-211.1%
Return on assets
-92.31%
Return on sales
0%
Return on invested capital
102.76%
Total debt ratio
1019.35%
Debt ratio change over timeo
1.04%
Current Ratio
1.31%
Quick Ratio
0%
Cash Position Ratio
0.71%
Short-term ratios 2019 - 2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-389.75%
Return on assets
-38.43%
Return on sales
0%
Return on invested capital
58.93%
Total debt ratio
82.75%
Debt ratio change over timeo
0.11%
Current Ratio
1.53%
Quick Ratio
0%
Cash Position Ratio
1.2%
Last quarter ratios 2020
The data are presented for the financials results of the last quarter.
Return on equity
-640.4%
Return on assets
-46.75%
Return on sales
0%
Return on invested capital
52.8%
Total debt ratio
92.45%
Debt ratio change over time
0.52%
Current Ratio
1.07%
Quick Ratio
0%
Cash Position Ratio
1.05%
Performance ratios (change over 4 years) 2016 - 2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-497.06%
Return on assets
-152.22%
Return on sales
0%
Return on invested capital
-0.53%
Total debt ratio
103.64%
Debt ratio change over time
1.04%
Current Ratio
0.87%
Quick Ratio
0%
Cash Position Ratio
0.33%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MITO | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -211.1% | 0% | 0% | 32.94% |
| Return on assets | -92.31% | 0% | 0% | -9.88% |
| Return on sales | 0% | 0% | 0% | -1451.74% |
| Return on invested capital | 102.76% | 0% | 0% | 38.19% |
| Profitability | 50% | 0% | 25% | 34% |
| Total debt ratio | 1019.35% | 0% | 0% | 191.06% |
| Debt ratio change over time | 1.04% | 0% | 0% | 20.42% |
| Dept financing | 26% | 0% | 0% | 30% |
| Current Ratio | 1.53% | 0% | 0% | 3.57% |
| Quick Ratio | 0% | 0% | 0% | 3.57% |
| Cash Position Ratio | 1.2% | 0% | 0% | 3.48% |
| Liquididy | 15% | 0% | 0% | 75% |
| Short-term ratios | MITO | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -389.75% | 0% | 0% | 16.85% |
| Return on assets | -38.43% | 0% | 0% | -15.81% |
| Return on sales | 0% | 0% | 0% | -3194.77% |
| Return on invested capital | 58.93% | 0% | 0% | 64.42% |
| Profitability | 48% | 0% | 25% | 50% |
| Total debt ratio | 82.75% | 0% | 0% | 91.27% |
| Debt ratio change over time | 0.11% | 0% | 0% | 0.42% |
| Dept financing | 29% | 0% | 0% | 50% |
| Current Ratio | 1.53% | 0% | 0% | 3.57% |
| Quick Ratio | 0% | 0% | 0% | 3.57% |
| Cash Position Ratio | 1.2% | 0% | 0% | 3.48% |
| Liquididy | 19% | 0% | 0% | 75% |